[Federal Register Volume 68, Number 72 (Tuesday, April 15, 2003)]
[Notices]
[Pages 18261-18262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-9228]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 13, 2002, Chattem 
Chemicals, Inc., 3801 St.

[[Page 18262]]

Elmo Avenue, Building 18 Chattanooga, Tennessee 37409, made application 
by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substance listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)..................  I
4-Methoxyamphetamine (7411)................  I
2,5-Dimethoxyamphetamine (7396)............  I
Difenoxin (9168)...........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Methylphenidate (1724).....................  II
Secobarbital (2315)........................  II
Meperidine (9230)..........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Diphenoxylate (9170).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
Dextropropoxyphene (9273)..................  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture the listed controlled substances 
to produce products for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD), and must be filed no later than 60 days from publication.

    Dated: April 3, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-9228 Filed 4-14-03; 8:45 am]
BILLING CODE 4410-09-M